Etiologies and Management of Rapid-Onset Eosinophilia

Primary Etiologic Categories by Clinical Context

Helminth infections, particularly tissue-invasive parasites during their migratory phase, represent the most common identifiable cause of rapid-onset eosinophilia in travelers and migrants (19-80% of cases), followed by drug reactions and acute allergic processes in non-travelers 1, 2
The American College of Physicians recommends that patients with eosinophilia be evaluated for helminth infections, especially if they have a history of travel to endemic areas 1

Strongyloides stercoralis can persist lifelong and cause fatal hyperinfection syndrome in immunocompromised patients, presenting with larva currens, abdominal pain, and respiratory symptoms during migration phase 1, 2, 3
Hookworm (Ancylostoma duodenale, Necator americanus) causes marked eosinophilia with "ground itch" at skin penetration, followed by Loeffler's syndrome during lung migration 1, 3
Schistosomiasis presents with acute Katayama syndrome 2-8 weeks post-exposure, characterized by fever, urticaria, hepatosplenomegaly, and marked eosinophilia, with freshwater exposure in Africa being a key historical clue 1, 4, 3

Allergic and drug-related causes constitute approximately 80% of eosinophilia in non-travelers, though these rarely cause rapid, severe elevations seen with parasites 2, 5
Drug reactions, such as those caused by NSAIDs, beta-lactam antibiotics, and nitrofurantoin, are common culprits, with onset typically within days to weeks of medication initiation 2, 5

The Centers for Disease Control and Prevention recommends obtaining a detailed travel history, including geographic regions visited, freshwater exposure, and consumption of raw or undercooked meat, to guide diagnostic testing for helminth infections 1, 2, 3, 4, 5
Three separate concentrated stool specimens for ova and parasites, strongyloides serology and culture, and schistosomiasis serology if freshwater exposure in endemic areas are recommended initial diagnostic tests 1, 2, 3, 4, 5

Empirical treatment for suspected helminth infection includes albendazole 400 mg plus ivermectin 200 μg/kg as single doses, covering most tissue-invasive helminths 3, 1
Specific helminth treatments, such as albendazole for hookworm, ivermectin for strongyloides, and praziquantel for schistosomiasis, are recommended based on the identified cause of eosinophilia 1, 3, 6
Corticosteroids are indicated for acute Katayama syndrome, angiostrongylus meningitis, severe trichinellosis, and neurocysticercosis to prevent inflammatory complications from parasite death 1, 4, 6